Table 1.

Patient Characteristics

Total no.  35  
Age (yr)  
 Median  29  
 Range 17-50  
Follow-up (mo)  
 Median  47  
 Range 19-84  
Sex  
 Male  14  
 Female  21 
Status at ABMT  
 First CR  4  
 First PR  8 
 Primarily refractory  12  
 Relapsed  11  
Response to salvage chemotherapy  
 CR  2  
 PR  7  
 Stable or progressive disease  16  
No. of chemotherapy regimens pre-ABMT 
 1  10  
 2  16  
 ≥3  9  
Chemotherapy responsiveness at ABMT  
 Responsive  20  
 Nonresponsive 15  
Prior marrow involvement  2  
Source of progenitor cells  
 Peripheral blood hematopoietic cells  2  
 Marrow alone  22  
 Both  11  
Radiation therapy  
 Initial therapy  8  
 Salvage therapy  4  
 ABMT consolidation 14 
Total no.  35  
Age (yr)  
 Median  29  
 Range 17-50  
Follow-up (mo)  
 Median  47  
 Range 19-84  
Sex  
 Male  14  
 Female  21 
Status at ABMT  
 First CR  4  
 First PR  8 
 Primarily refractory  12  
 Relapsed  11  
Response to salvage chemotherapy  
 CR  2  
 PR  7  
 Stable or progressive disease  16  
No. of chemotherapy regimens pre-ABMT 
 1  10  
 2  16  
 ≥3  9  
Chemotherapy responsiveness at ABMT  
 Responsive  20  
 Nonresponsive 15  
Prior marrow involvement  2  
Source of progenitor cells  
 Peripheral blood hematopoietic cells  2  
 Marrow alone  22  
 Both  11  
Radiation therapy  
 Initial therapy  8  
 Salvage therapy  4  
 ABMT consolidation 14 
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal